Watch for the S-1 registration statement filing by November 19, 2026 (35 days after Oct 15). If delayed, the 2% monthly penalty accelerates cash cost. Also monitor the Nasdaq stockholder vote on the management/director units — failure to obtain approval would return $250K to subscribers but remove a potential insider signal.
Price Chart
Executive Summary
Conexeu Sciences Inc. disclosed multiple unregistered securities sales from September 14 to October 15, 2026, including a private placement of 1,333,333 Units at $3.00/Unit for $4.0M gross proceeds, plus 250,000 Special Warrants at $3.00 each for $750,000, and various consultant stock issuances and warrant exercises. The aggregate issuances exceeded 5% of outstanding shares, triggering this Item 3.02 disclosure. The company also agreed to file an S-1 registration statement for resale of the shares and warrant shares within 35 days, with a 2% monthly penalty for delay.
Key Financial Metrics
Key Facts
- Issued 1,333,333 Units at $3.00/Unit to three accredited investors for $3,999,999 gross proceeds; each Unit = 1 share + 1 warrant exercisable at $3.00 for 24 months
- Issued 250,000 Special Warrants at $3.00 each to two Canadian accredited investors for $750,000; automatically convert into 1 share + 1 warrant by Feb 16, 2027
- Management/directors subscribed for 83,334 Units at $3.00 for $250,002, held in escrow pending Nasdaq stockholder approval under Rule 5635(c)
- Issued 1,290,000 shares to consultants and via warrant exercises at prices from $0.001 to $4.75 per share
- Company agreed to file S-1 registration statement for resale of shares and warrant shares within 35 days, with 2% monthly liquidated damages penalty for delay
- Beneficial ownership limitations of 4.99% or 9.99% apply to warrant shares for certain subscribers
Financial Impact
Total gross proceeds of approximately $4.75M from the private placement and special warrants, plus $1,250 from warrant exercises and consultant shares at deemed prices. Dilution from the 1,333,333 Units alone represents a significant percentage of outstanding shares, and the additional 250,000 special warrants and 83,334 escrowed units add further potential dilution.
Risk Factors
- Significant dilution from up to 1,666,667 shares and 1,666,667 warrants from the private placement and special warrants, plus 83,334 escrowed units
- S-1 registration triggers near-term resale overhang; failure to file on time triggers 2% monthly cash penalty
- Warrant exercise at $3.00/share may pressure stock if price remains near or below that level
- Nasdaq stockholder approval requirement for management/director units introduces execution risk
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001062993-26-005431 |
| Document: 0001062993-26-005431-index-headers.html | 0001062993-26-005431 |
| Document: 0001062993-26-005431-index.html | 0001062993-26-005431 |
| Document: 0001062993-26-005431.txt | 0001062993-26-005431 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 8-K | $3.33 $3.30 | ▲ +0.90% | ▼ −0.28% | $2.96 (+10.96%) |
Oct 15, 2026 11d ago | Press Release | $3.06 $3.29 | ▲ +7.52% | ▲ +7.09% | $2.96 (−3.10%) |
Oct 6, 2026 21d ago | Press Release | $3.66 $3.64 | ▼ −0.55% | ▼ −0.31% | $2.96 (−18.99%) |
Jun 29, 2026 17w ago | 3 | $10.24 $10.92 | ▲ +6.64% | ▲ +5.86% | $2.96 (−71.04%) |
Jun 23, 2026 17w ago | Insider Buy | $10.69 $10.22 | ▼ −4.40% | ▼ −4.54% | $2.96 (−72.26%) |
Jun 3, 2026 20w ago | Press Release | $16.85 $16.00 | ▼ −5.04% | ▼ −5.44% | $2.96 (−82.40%) |
May 14, 2026 23w ago | Insider Cluster | — | awaiting T+1 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers